Glucocorticoid signaling mitigates colitis-associated visceral hypersensitivity by suppressing 5-HT release in enterochromaffin cells via a GR-PI3K-SGK1 axis
International Immunopharmacology · 2026-03 · 172 · 116207
DOI: 10.1016/j.intimp.2026.116207 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026-03. Verfasst von Dongping Lyu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan 250012, China; Laboratory of Translational Gastroenterology, Qilu Hospital,…. Hauptthemen laut MEDLINE: Enterochromaffin Cells, Serotonin, Colitis, Glucocorticoids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Shandong University, National Natural Science Foundation of China.
Abstract (Originalsprache)
The phenomenon of inflammatory bowel disease (IBD) patients experiencing irritable bowel syndrome (IBS)-like symptoms, particularly during periods of endoscopic remission, is a significant and well-documented clinical challenge. Increased 5-hydroxytryptamine (5-HT) availability from enterochromaffin (EC) cells is implicated in visceral hypersensitivity, a hallmark of IBS. While glucocorticoids are effective in IBD, their potential to alleviate IBS symptoms and their interaction with gut 5-HT system remain unexplored. A murine model of colitis-associated visceral hypersensitivity was established in epithelium-specific Tph1 knockout mice. After dexamethasone treatment, visceral hypersensitivity was assessed by both behavioral test and electromyography. 5-HT synthesis was analyzed via flow cytometry, ELISA, immunohistochemistry, and qPCR. In vitro mechanistic studies were performed in QGP-1 cells using RNA sequencing, western blot, and pharmacological inhibitors. In the murine model of colitis-associated visceral hypersensitivity, dexamethasone effectively alleviated visceral hypersensitivity, which was abolished by the epithelium-specific knockout of Tph1. Dexamethasone treatment significantly downregulated peripheral 5-HT biosynthesis by reducing Tph1 expression in EC cells. Abundant GR expression in EC cells was confirmed by single-cell transcriptomic analysis and immunofluorescence. In QGP-1 cells, dexamethasone dose-dependently suppressed TPH1 and 5-HT production in a GR-dependent manner. Mechanistically, transcriptomic profiling revealed dexamethasone-induced activation of the PI3K signaling pathway, and subsequent pharmacological inhibition experiments established that dexamethasone represses TPH1 through a GR-PI3K-SGK1 signaling axis. This study identified a novel GR-PI3K-SGK1 signaling axis in EC cells that downregulates 5-HT synthesis and alleviates visceral hypersensitivity. Our findings revealed a non-classical mechanism for glucocorticoids and highlighting their potential use in managing IBS-like symptoms in IBD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan 250012, China; Laboratory of Translational Gastroenterology, Qilu Hospital, Shandong University, Jinan 250012, China; Shandong Provincial Clinica…
- Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan 250012, China; Shandong Provincial Clinical Research Center for digestive disease, Qilu Hospital, Shandong University, Jinan 250012, China; Advan…
Förderung
- Shandong University
- National Natural Science Foundation of China
Zitieren
APA
Lyu, D., Wang, X., Zhang, J., Fu, S., Li, L., Li, S., Li, Y., & Zuo, X. (2026). Glucocorticoid signaling mitigates colitis-associated visceral hypersensitivity by suppressing 5-HT release in enterochromaffin cells via a GR-PI3K-SGK1 axis. International Immunopharmacology, 172, 116207. https://doi.org/10.1016/j.intimp.2026.116207
Vancouver
Lyu D, Wang X, Zhang J, Fu S, Li L, Li S, et al. Glucocorticoid signaling mitigates colitis-associated visceral hypersensitivity by suppressing 5-HT release in enterochromaffin cells via a GR-PI3K-SGK1 axis. International Immunopharmacology. 2026;172:116207. doi:10.1016/j.intimp.2026.116207
BibTeX
@article{Lyu2026,
author = {Lyu, Dongping and Wang, Xia and Zhang, Jinghui and Fu, Shichen and Li, Lixiang and Li, Shiyang and Li, Yanqing and Zuo, Xiuli},
title = {Glucocorticoid signaling mitigates colitis-associated visceral hypersensitivity by suppressing 5-HT release in enterochromaffin cells via a GR-PI3K-SGK1 axis},
journal = {International Immunopharmacology},
year = {2026},
volume = {172},
pages = {116207},
doi = {10.1016/j.intimp.2026.116207}
}
EUVIMED